Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)

Please use this identifier to cite or link to this item: https://doi.org/10.1002/pbc.20684

Title:	Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)
Authors:	Kwok, C.S. Kham, S.K. Quah, T.C. Yeoh, A.E. Ariffin, H. Lin, H.P.
Keywords:	ALL Drug efficacy L-asparaginase Leukemia Minimal residual disease
Issue Date:	2006
Citation:	Kwok, C.S., Kham, S.K., Quah, T.C., Yeoh, A.E., Ariffin, H., Lin, H.P. (2006). Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL). Pediatric Blood and Cancer 47 (3) : 299-304. ScholarBank@NUS Repository. https://doi.org/10.1002/pbc.20684
Source Title:	Pediatric Blood and Cancer
URI:	http://scholarbank.nus.edu.sg/handle/10635/25684
ISSN:	15455009 15455017
DOI:	10.1002/pbc.20684
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check